| UniProt ID | POLH_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y253 | |
| Protein Name | DNA polymerase eta | |
| Gene Name | POLH | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 713 | |
| Subcellular Localization |
Nucleus . Accumulates at replication forks after DNA damage (PubMed:12606586). After UV irradiation, recruited to DNA damage sites within 1 hour, to a maximum of about 80% this recruitment may not be not restricted to cells active in DNA replication |
|
| Protein Description | DNA polymerase specifically involved in the DNA repair by translesion synthesis (TLS). [PubMed: 10385124] | |
| Protein Sequence | MATGQDRVVALVDMDCFFVQVEQRQNPHLRNKPCAVVQYKSWKGGGIIAVSYEARAFGVTRSMWADDAKKLCPDLLLAQVRESRGKANLTKYREASVEVMEIMSRFAVIERASIDEAYVDLTSAVQERLQKLQGQPISADLLPSTYIEGLPQGPTTAEETVQKEGMRKQGLFQWLDSLQIDNLTSPDLQLTVGAVIVEEMRAAIERETGFQCSAGISHNKVLAKLACGLNKPNRQTLVSHGSVPQLFSQMPIRKIRSLGGKLGASVIEILGIEYMGELTQFTESQLQSHFGEKNGSWLYAMCRGIEHDPVKPRQLPKTIGCSKNFPGKTALATREQVQWWLLQLAQELEERLTKDRNDNDRVATQLVVSIRVQGDKRLSSLRRCCALTRYDAHKMSHDAFTVIKNCNTSGIQTEWSPPLTMLFLCATKFSASAPSSSTDITSFLSSDPSSLPKVPVTSSEAKTQGSGPAVTATKKATTSLESFFQKAAERQKVKEASLSSLTAPTQAPMSNSPSKPSLPFQTSQSTGTEPFFKQKSLLLKQKQLNNSSVSSPQQNPWSNCKALPNSLPTEYPGCVPVCEGVSKLEESSKATPAEMDLAHNSQSMHASSASKSVLEVTQKATPNPSLLAAEDQVPCEKCGSLVPVWDMPEHMDYHFALELQKSFLQPHSSNPQVVSAVSHQGKRNPKSPLACTNKRPRPEGMQTLESFFKPLTH | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 32 | Ubiquitination | QNPHLRNKPCAVVQY CCCCCCCCCEEEEEE | 34.73 | - | |
| 70 | Ubiquitination | MWADDAKKLCPDLLL HHHHHHHHHCHHHHH | 57.98 | - | |
| 86 | Acetylation | QVRESRGKANLTKYR HHHHHCCCCCCHHHH | 32.75 | 18525633 | |
| 90 | Phosphorylation | SRGKANLTKYREASV HCCCCCCHHHHHHHH | 26.32 | 27174698 | |
| 91 | Ubiquitination | RGKANLTKYREASVE CCCCCCHHHHHHHHH | 45.54 | - | |
| 92 | Phosphorylation | GKANLTKYREASVEV CCCCCHHHHHHHHHH | 14.40 | 27174698 | |
| 96 | Phosphorylation | LTKYREASVEVMEIM CHHHHHHHHHHHHHH | 17.66 | 27174698 | |
| 104 | Phosphorylation | VEVMEIMSRFAVIER HHHHHHHHHHHHHHH | 29.88 | 24043423 | |
| 118 | Phosphorylation | RASIDEAYVDLTSAV HCCCCHHHHHHHHHH | 7.76 | 25332170 | |
| 122 | Phosphorylation | DEAYVDLTSAVQERL CHHHHHHHHHHHHHH | 15.35 | 25332170 | |
| 123 | Phosphorylation | EAYVDLTSAVQERLQ HHHHHHHHHHHHHHH | 33.47 | 25332170 | |
| 131 (in isoform 2) | Ubiquitination | - | 47.58 | 21906983 | |
| 131 (in isoform 1) | Ubiquitination | - | 47.58 | 21890473 | |
| 131 | Ubiquitination | AVQERLQKLQGQPIS HHHHHHHHHCCCCCC | 47.58 | 21906983 | |
| 163 | Sumoylation | TAEETVQKEGMRKQG CHHHHHHHHHHHHCC | 52.48 | - | |
| 213 | Phosphorylation | RETGFQCSAGISHNK HHHCCCCCCCCCCHH | 20.81 | 22210691 | |
| 224 | Acetylation | SHNKVLAKLACGLNK CCHHHHHHHHCCCCC | 32.24 | 19810443 | |
| 224 | Ubiquitination | SHNKVLAKLACGLNK CCHHHHHHHHCCCCC | 32.24 | - | |
| 231 | Ubiquitination | KLACGLNKPNRQTLV HHHCCCCCCCCCHHH | 49.03 | - | |
| 242 | Phosphorylation | QTLVSHGSVPQLFSQ CHHHCCCCHHHHHHC | 25.79 | - | |
| 311 | Ubiquitination | GIEHDPVKPRQLPKT CCCCCCCCHHCCCCC | 39.61 | - | |
| 317 | Acetylation | VKPRQLPKTIGCSKN CCHHCCCCCCCCCCC | 62.46 | 12656637 | |
| 323 | Ubiquitination | PKTIGCSKNFPGKTA CCCCCCCCCCCCCCC | 67.68 | - | |
| 369 | Phosphorylation | VATQLVVSIRVQGDK HEEEEEEEEEECCCH | 9.37 | - | |
| 376 | Ubiquitination | SIRVQGDKRLSSLRR EEEECCCHHHHHHHH | 63.16 | - | |
| 379 | Phosphorylation | VQGDKRLSSLRRCCA ECCCHHHHHHHHHHH | 31.21 | 22167270 | |
| 380 | Phosphorylation | QGDKRLSSLRRCCAL CCCHHHHHHHHHHHH | 30.41 | 22167270 | |
| 396 | Phosphorylation | RYDAHKMSHDAFTVI HHHHHHCCCCCEEEE | 24.02 | 27251275 | |
| 401 | Phosphorylation | KMSHDAFTVIKNCNT HCCCCCEEEECCCCC | 24.04 | 27251275 | |
| 408 | Phosphorylation | TVIKNCNTSGIQTEW EEECCCCCCCCCCCC | 30.45 | 27251275 | |
| 409 | Phosphorylation | VIKNCNTSGIQTEWS EECCCCCCCCCCCCC | 21.65 | 27251275 | |
| 413 (in isoform 2) | Phosphorylation | - | 37.18 | 28842319 | |
| 413 | Phosphorylation | CNTSGIQTEWSPPLT CCCCCCCCCCCCCCH | 37.18 | 27251275 | |
| 416 | Phosphorylation | SGIQTEWSPPLTMLF CCCCCCCCCCCHHHH | 15.48 | 27251275 | |
| 427 | Phosphorylation | TMLFLCATKFSASAP HHHHHHHHHCCCCCC | 31.46 | 27251275 | |
| 453 | Ubiquitination | SDPSSLPKVPVTSSE CCCCCCCCCCCCCHH | 65.55 | - | |
| 457 | O-linked_Glycosylation | SLPKVPVTSSEAKTQ CCCCCCCCCHHHCCC | 22.06 | 30059200 | |
| 462 | Ubiquitination | PVTSSEAKTQGSGPA CCCCHHHCCCCCCCC | 37.01 | 21906983 | |
| 462 (in isoform 1) | Ubiquitination | - | 37.01 | 21890473 | |
| 486 | Ubiquitination | SLESFFQKAAERQKV HHHHHHHHHHHHHHH | 44.39 | - | |
| 510 | Phosphorylation | APTQAPMSNSPSKPS CCCCCCCCCCCCCCC | 32.85 | 25159151 | |
| 512 | Phosphorylation | TQAPMSNSPSKPSLP CCCCCCCCCCCCCCC | 24.20 | 27050516 | |
| 514 | Phosphorylation | APMSNSPSKPSLPFQ CCCCCCCCCCCCCCC | 57.95 | 25159151 | |
| 517 | Phosphorylation | SNSPSKPSLPFQTSQ CCCCCCCCCCCCCCC | 53.03 | 28348404 | |
| 522 | Phosphorylation | KPSLPFQTSQSTGTE CCCCCCCCCCCCCCC | 29.16 | 28348404 | |
| 523 | Phosphorylation | PSLPFQTSQSTGTEP CCCCCCCCCCCCCCC | 16.02 | 28348404 | |
| 547 | Phosphorylation | KQKQLNNSSVSSPQQ HHHHHCCCCCCCCCC | 30.92 | 25627689 | |
| 548 | Phosphorylation | QKQLNNSSVSSPQQN HHHHCCCCCCCCCCC | 28.30 | 25627689 | |
| 550 | Phosphorylation | QLNNSSVSSPQQNPW HHCCCCCCCCCCCCC | 37.94 | 25627689 | |
| 551 | Phosphorylation | LNNSSVSSPQQNPWS HCCCCCCCCCCCCCC | 25.27 | 25627689 | |
| 566 | Phosphorylation | NCKALPNSLPTEYPG CCCCCCCCCCCCCCC | 33.51 | 26714015 | |
| 569 | Phosphorylation | ALPNSLPTEYPGCVP CCCCCCCCCCCCCEE | 54.14 | 26714015 | |
| 587 | Phosphorylation | GVSKLEESSKATPAE CHHHHHHHCCCCHHH | 27.97 | 18946034 | |
| 601 | Phosphorylation | EMDLAHNSQSMHASS HHHHHHHHCHHCCHH | 17.48 | 21242293 | |
| 603 | Phosphorylation | DLAHNSQSMHASSAS HHHHHHCHHCCHHHC | 16.62 | 26714015 | |
| 617 | Phosphorylation | SKSVLEVTQKATPNP CHHHHHHHHCCCCCH | 18.25 | 18946034 | |
| 619 | Ubiquitination | SVLEVTQKATPNPSL HHHHHHHCCCCCHHH | 44.88 | - | |
| 682 | Ubiquitination | SAVSHQGKRNPKSPL HCEECCCCCCCCCCC | 42.29 | 21890473 | |
| 682 (in isoform 1) | Ubiquitination | - | 42.29 | 21890473 | |
| 686 | Ubiquitination | HQGKRNPKSPLACTN CCCCCCCCCCCCCCC | 69.15 | 20159558 | |
| 687 | Phosphorylation | QGKRNPKSPLACTNK CCCCCCCCCCCCCCC | 26.80 | 25849741 | |
| 694 | Ubiquitination | SPLACTNKRPRPEGM CCCCCCCCCCCCCHH | 45.70 | 20159558 | |
| 709 | Ubiquitination | QTLESFFKPLTH--- HHHHHHHCCCCC--- | 36.79 | 20159558 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 601 | S | Phosphorylation | Kinase | ATR | Q13535 | PSP |
| 687 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
| - | K | Ubiquitination | E3 ubiquitin ligase | RCHY1 | Q96PM5 | PMID:22199232 |
| - | K | Ubiquitination | E3 ubiquitin ligase | DTL | Q9NZJ0 | PMID:29208956 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of POLH_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of POLH_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| OMIM Disease | ||||||
| 278750 | Xeroderma pigmentosum variant type (XPV) | |||||
| Kegg Drug | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379 AND SER-380, ANDMASS SPECTROMETRY. | |
| "Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379 AND SER-380, ANDMASS SPECTROMETRY. | |